Drug maker Eli Lilly’s share price plunged Wednesday morning after the company reported worse third-quarter results than expected, especially in its weight-loss drug division, registering a rare ...

Paulo Nunes dos Santos / Bloomberg via Getty Images Eli Lilly will report third-quarter earnings Wednesday morning, with the focus remaining on the production and sales of its popular weight-loss ...

AJ Mast / Bloomberg via Getty Images Eli Lilly (LLY) shares tumbled 12% at the opening bell Wednesday after its third-quarter results fell well short of analysts' estimates and it lowered its full ...

Eli Lilly has seen tremendous growth from its new GLP-1 drugs, which people have been using for weight loss. Sales growth should continue as the company increases production and looks to win ...

Former New York Giants quarterback Eli Manning headlines six first-year eligible candidates voted as semifinalists for election into the Pro Football Hall of Fame's class of 2025, as announced on ...

Eli Lilly's business is growing fast, but it wasn't enough for analysts and investors. It also slashed its earnings guidance for the year. The stock has been trading at a high valuation, and that ...

Former New York Giants quarterback Eli Manning is one of 25 players eligible for the Pro Football Hall of Fame Class of 2025. While Manning's two Super Bowl victories under center for the Giants ...

A change in the dosing regimen of Eli Lilly’s Alzheimer’s drug Kisunla resulted in a lower rate of brain swelling among patients in a clinical trial, new data reported Tuesday show.

Jackson's Eli Ilg and Lake's Daniela Scheffler defended their Division I regional cross country titles Saturday at Boardman. Scheffler's time of 17:20.84 was a girls course record. Ilg will be ...

Eli Lilly on Wednesday fell short of profit and revenue expectations for the third quarter, weighed down by disappointing sales of its blockbuster weight loss drug Zepbound and diabetes treatment ...

Oct 27 (Reuters) - Eli Lilly (LLY.N), opens new tab expects to start selling its weight-loss drug in Hong Kong as early as the end of this year, Bloomberg News reported, opens new tab on Sunday.